You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 1, January 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Topical Fosfomycin on Polymyxin B Ototoxicity

Joseph L. Leach, MD; Charles G. Wright, PhD; Laura B. Edwards; William L. Meyerhoff, MD, PhD

Arch Otolaryngol Head Neck Surg. 1990;116(1):49-53.


Abstract

• Fosfomycin is an antibiotic that has been found to reduce the ototoxicity of aminoglycoside antibiotics and cisplatin when systemically coadministered. Polymyxin B, an antibiotic frequently used in ototopical preparations, has been shown to be ototoxic in experimental studies. To investigate the effect of fosfomycin on polymyxin B ototoxicity, topical administration of the two agents into the middle ear cavity was performed. Two groups of chinchillas were used. One group received applications of polymyxin B alone, and the second group received polymyxin B combined with fosfomycin. It was found that application of polymyxin B produces severe damage to the cochlea. However, when polymyxin B was given in combination with fosfomycin, cochlear damage was dramatically reduced. It is likely that in clinical use, a combination of polymyxin B and fosfomycin would demonstrate reduced risk of ototoxicity.

(Arch Otolaryngol Head Neck Surg. 1990;116:49-53)



Author Affiliations

From the Department of Otorhinolaryngology, University of Texas Southwestern Medical Center, Dallas.


Footnotes

Accepted for publication June 6, 1989.

Reprint requests to Callier Center for Communication Disorders, 1966 Inwood Rd, Dallas, TX 75235 (Dr Wright).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methicillin-Resistant Staphylococcus aureus Otorrhea After Tympanostomy Tube Placement: An Emerging Concern
Hartnick et al.
Arch Otolaryngol Head Neck Surg 2000;126:1440-1443.
ABSTRACT | FULL TEXT  

In Vitro Interaction of Cisplatin and Fosfomycin on Squamous Cell Carcinoma Cultures
Olson et al.
Arch Otolaryngol Head Neck Surg 1994;120:1253-1257.
ABSTRACT  

Side Effects of Repeated Ototopical Application of Fosfomycin: An Animal Study
Claes et al.
Arch Otolaryngol Head Neck Surg 1992;118:951-955.
ABSTRACT  

Ciprofloxacin: Use as a Topical Otic Preparation
Brownlee et al.
Arch Otolaryngol Head Neck Surg 1992;118:392-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.